A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Participants With Chronic Heart Failure With Reduced Ejection Fraction
Clinical trial NCT04836182 · COMPLETED
Trial details
- NCT number
- NCT04836182
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-08
- Primary completion
- 2022-10-19
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.